Liver, colon, gastric, pancreatic, and lung cancer
Conditions
Interventions
gastric carcinoma group:No
Sponsors
Tongji Chibi Hospital of Huazhong University of Science and Technology (Chibi Pufang Hospital)
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients who are clinically diagnosed as late, middle or late stage by histology and cytology; 2. Life expectancy of at least 12 weeks; 3. No more than 3 lesions; 4. The oncologist judges the patients who can be treated with FMT; 5. Men and women are not limited. Aged 18 to 80 years; 6. Cartensite energy status score >= 70; 7. No grade 3 hypertension, no coronary heart disease, respiratory system and other diseases, good liver function (total bilirubin (T.BIL) <75µMOL/L, direct bilirubin (D.BIL) <39µMOL/L and CHILD-PUGH score A or B); 8. The subjects voluntarily joined the study, signed the informed consent form, had good compliance, and cooperated with the follow-up.
Exclusion criteria
Exclusion criteria: 1. Complicated infections of extraintestinal organs, such as pneumonia, peritonitis, and pleural abscess disease, require antibiotic treatment; 2. Patients with active infection (HAV, HBV, HCV, HIV, syphilis, tuberculosis infection); 3. Severe heart, lung, liver and kidney insufficiency; 4. Severe anemia (Hb<6gdl/g), multiple lymphadenopathy, leukopenia, etc.; 5. Pregnant women or patients with pregnancy plans; 6. Other excluded items will be checked in detail in the outpatient clinic according to the research plan.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| objective response rate;progression-free survival;overall survival;serum albumin;safety; | — |
Secondary
| Measure | Time frame |
|---|---|
| 16S intestinal microflora health assessment;Immune function; | — |
Countries
China
Contacts
Public ContactMohammed Alnaggar
Tongji Chibi Hospital of Huazhong University of Science and Technology (Chibi Pufang Hospital)
Outcome results
None listed